Compared to the controls, enrichment of BRCA1 variants in lung cancer patients was statistically significant, with an OR of 4.193 (95% CI 1.382–10.768, p = 0.006), but it was not significant for BRCA2. The gene discussed is BRCA2; the disease is lung cancer.